[Answered] Concurrent jurisdiction. What will be an ideal response? ...

This topic contains a solution. Click here to go to the answer

« previous next »

Author Question: Concurrent jurisdiction. What will be an ideal response? ... (Read 34 times)

fox

Hero Member
Posts: 540

on: Aug 3, 2018

Concurrent jurisdiction.

What will be an ideal response?

Question 2

Removal.

What will be an ideal response?

Need homework help now?

Ask unlimited questions for free

Ask a Question

Marked as best answer by a Subject Expert

sultana.d

Sr. Member
Posts: 320

Reply #1 on: Aug 3, 2018

Answer to Question 1

When state courts can hear the same claims as federal courts.

Answer to Question 2

When upon defendant's request, a case is moved from state to federal court.

fox

Member
Posts: 540

Reply 2 on: Aug 3, 2018

TYSM

31809pancho

Member
Posts: 317

Reply 3 on: Yesterday

Great answer, keep it coming

« previous next »

Did you know?

Computer programs are available that crosscheck a new drug's possible trade name with all other trade names currently available. These programs detect dangerous similarities between names and alert the manufacturer of the drug.

Did you know?

The most dangerous mercury compound, dimethyl mercury, is so toxic that even a few microliters spilled on the skin can cause death. Mercury has been shown to accumulate in higher amounts in the following types of fish than other types: swordfish, shark, mackerel, tilefish, crab, and tuna.

Did you know?

Hypertension is a silent killer because it is deadly and has no significant early symptoms. The danger from hypertension is the extra load on the heart, which can lead to hypertensive heart disease and kidney damage. This occurs without any major symptoms until the high blood pressure becomes extreme. Regular blood pressure checks are an important method of catching hypertension before it can kill you.

Did you know?

Aspirin is the most widely used drug in the world. It has even been recognized as such by the Guinness Book of World Records.

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.